Journey Medical Corp (DERM)
3.40
-0.10
(-2.86%)
USD |
NASDAQ |
Apr 26, 16:00
3.43
+0.03
(+0.88%)
After-Hours: 20:00
Journey Medical Price: 3.40 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 3.49 | 3.54 | 3.36 | 3.40 | 64845.00 |
Apr 25, 2024 | 3.40 | 3.57 | 3.347 | 3.50 | 46341.00 |
Apr 24, 2024 | 3.50 | 3.63 | 3.31 | 3.40 | 60474.00 |
Apr 23, 2024 | 3.50 | 3.59 | 3.45 | 3.54 | 75360.00 |
Apr 22, 2024 | 3.45 | 3.60 | 3.411 | 3.54 | 37549.00 |
Apr 19, 2024 | 3.51 | 3.64 | 3.40 | 3.48 | 102496.0 |
Apr 18, 2024 | 3.82 | 3.86 | 3.51 | 3.58 | 189103.0 |
Apr 17, 2024 | 3.77 | 3.90 | 3.615 | 3.86 | 129238.0 |
Apr 16, 2024 | 4.00 | 4.00 | 3.700 | 3.80 | 118561.0 |
Apr 15, 2024 | 4.36 | 4.39 | 4.00 | 4.02 | 135924.0 |
Apr 12, 2024 | 4.47 | 4.636 | 4.282 | 4.42 | 138724.0 |
Apr 11, 2024 | 4.35 | 4.55 | 3.90 | 4.31 | 295723.0 |
Apr 10, 2024 | 4.00 | 4.40 | 3.88 | 4.38 | 245243.0 |
Apr 09, 2024 | 4.11 | 4.18 | 3.86 | 4.00 | 106734.0 |
Apr 08, 2024 | 3.64 | 4.35 | 3.60 | 4.11 | 272430.0 |
Apr 05, 2024 | 4.26 | 4.315 | 3.61 | 3.68 | 313142.0 |
Apr 04, 2024 | 3.41 | 4.57 | 3.305 | 4.36 | 685013.0 |
Apr 03, 2024 | 3.37 | 3.48 | 3.34 | 3.42 | 63542.00 |
Apr 02, 2024 | 3.30 | 3.44 | 3.20 | 3.40 | 57534.00 |
Apr 01, 2024 | 3.55 | 3.55 | 3.23 | 3.31 | 291715.0 |
Mar 28, 2024 | 3.88 | 3.99 | 3.65 | 3.68 | 99042.00 |
Mar 27, 2024 | 3.70 | 3.98 | 3.580 | 3.89 | 122679.0 |
Mar 26, 2024 | 3.23 | 4.18 | 3.23 | 3.69 | 643433.0 |
Mar 25, 2024 | 3.27 | 3.27 | 2.85 | 2.92 | 423996.0 |
Mar 22, 2024 | 3.50 | 3.563 | 3.05 | 3.30 | 373474.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.035
Minimum
May 18 2023
9.50
Maximum
Nov 12 2021
3.443
Average
3.315
Median
Price Benchmarks
Fortress Biotech Inc | 1.72 |
Puma Biotechnology Inc | 5.02 |
GT Biopharma Inc | 3.345 |
FibroGen Inc | 1.04 |
Outlook Therapeutics Inc | 8.43 |
Price Related Metrics
PS Ratio | 0.8177 |
Price to Book Value | 3.330 |
Price to Free Cash Flow | 269.77 |
Earnings Yield | -10.29% |
Market Cap | 67.77M |
Operating PE Ratio | 60.51 |